share_log

Gilead Sciences Announces Topline Results From Phase 3 TROPiCS-04 Study In Metastatic Urothelial Cancer; Trodelvy Fails To Meet Primary Endpoint Of Overall Survival

Benzinga ·  May 31 04:45
Gilead Sciences Announces Topline Results From Phase 3 TROPiCS-04 Study In Metastatic Urothelial Cancer; Trodelvy Fails To Meet Primary Endpoint Of Overall Survival
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment